Co-Partners
Associate Partners
Get App

Co-Partners

Associate Partners

you are here: HomeNewsBusiness
Last Updated : Feb 12, 2019 11:37 AM IST | Source: PTI

Dr Reddy's launches erectile dysfunction treatment drug in US

Quoting IMS Health data, Dr Reddy's Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.

Representative Image
Representative Image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddy's Laboratories on Tuesday said it has launched Tadalafil tablets, used to treat erectile dysfunction, in the US market. Tadalafil tablets are a therapeutic equivalent generic version of Adcirca tablets, Dr Reddy's Laboratories said in a BSE filing.

Quoting IMS Health data, Dr Reddy's Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.

Shares of Dr Reddy's were trading 0.01 per cent lower at Rs 2,616.70 apiece on the BSE.
First Published on Feb 12, 2019 11:31 am
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant